Pacific Biomarkers Q2 Revenues Drop 35 Percent | GenomeWeb

Specialty biomarker and contract research services firm Pacific Biomarkers this week reported that revenues fell by 35 percent for its fiscal second quarter.

For the three months ended Dec. 31, 2009, the Seattle-based firm posted receipts of $2.1 million, compared to $3.2 million in the year-ago period. Net loss for the quarter was $457,629, or $0.03 per share, compared to a profit of $976,671, or $0.05 per share, a year ago.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.